Shanghai BioGerm Medical Technology Co., Ltd. was established in March 2017. It is committed to the research and development and application of molecular diagnostic reagents for infectious pathogens. It is deeply involved in the development of multiple fluorescent PCR diagnostic reagents, pathogen first-generation sequencing and trace virus second-generation sequencing reagents and related technologies. service. The company is committed to solving the problem of difficult diagnosis caused by genetic mutations of infectious pathogens. It has achieved the goal of making molecular ....
More

This PCR kit is designed for the qualitative detection of 2019-nCoV, and the results indicate the presence of 2019-nCoV nucleic acid and can be used to support the diagnosis of 2019-nCoV infection.

More

Continuous research and innovation to show the company's vigorous vitality

More
Understand related knowledge news, enrich our knowledge base through news discovery and more knowledge, thank you for watching.

For business cooperation, product consultation, technical support, etc., please contact us!
Contact Us